Literature DB >> 1885069

Fc receptor function and circulating immune complexes in gluten sensitive enteropathy--possible significance of serum IgA.

B Lavö1, B Nilsson, L Lööf, U R Nilsson, K N Ekdahl.   

Abstract

The capacity to clear IgG containing immune complexes from the circulation was studied in patients with coeliac disease (n = 13), dermatitis herpetiformis (n = 8), and coeliac disease with concomitant serum IgA deficiency (n = 4). A small group of patients with active ulcerative colitis (n = 4) was included as a bowel disease control group. Clearance was estimated by measuring the disappearance rate of a bolus dose of intravenously injected IgG coated autologous erythrocytes. The mean T1/2 of clearance was prolonged in both coeliac disease (86 (24) minutes) and dermatitis herpetiformis (111 (35) minutes), compared with healthy subjects (20 (5) minutes) and coeliac patients with concomitant serum IgA deficiency (T1/2 = 17 (6) minutes). Patients with ulcerative colitis had a prolonged clearance, with a T1/2 of 195 (63) minutes. Values of circulating immune complexes were measured by four assays; C1q binding and C3, IgG, and IgA containing immune complexes. C1q binding immune complexes were detected only in IgA deficient gluten sensitive enteropathy. Patients with coeliac disease and dermatitis herpetiformis had higher values of C3, IgG, and IgA containing immune complexes than control subjects and serum IgA deficient patients with coeliac disease. The clearance rate was inversely correlated to the amount of immune complexes for the subgroups of gluten sensitive enteropathy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1885069      PMCID: PMC1378955          DOI: 10.1136/gut.32.8.876

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  38 in total

1.  Autoantibodies in dermatitis herpetiformis.

Authors:  N G Fraser
Journal:  Br J Dermatol       Date:  1970-12       Impact factor: 9.302

2.  Development of an immunoassay for the detection of minute amounts of IgG-coated erythrocytes in whole blood and its application for the assessment of Fc-mediated clearance of anti-D-coated erythrocytes in vivo.

Authors:  K Nilsson Ekdahl; L Lööf; U R Nilsson; B Nilsson
Journal:  Vox Sang       Date:  1989       Impact factor: 2.144

3.  Polymeric IgA and IgA rheumatoid factor decrease the capacity of serum to solubilize circulating immune complexes in patients with primary IgA nephropathy.

Authors:  P F Schena; A Pastore; R A Sinico; V Montinaro; A Fornasieri
Journal:  J Immunol       Date:  1988-07-01       Impact factor: 5.422

4.  Clearance of soluble aggregates of human immunoglobulin G in healthy volunteers and chimpanzees.

Authors:  S Lobatto; M R Daha; A A Voetman; J H Evers-Schouten; A A Van Es; E K Pauwels; L A Van Es
Journal:  Clin Exp Immunol       Date:  1987-07       Impact factor: 4.330

5.  Activation of the alternative pathway of complement by human serum IgA.

Authors:  P S Hiemstra; A Gorter; M E Stuurman; L A Van Es; M R Daha
Journal:  Eur J Immunol       Date:  1987-03       Impact factor: 5.532

6.  Role of C3b receptors in the enhancement of interleukin-2-dependent T-cell proliferation.

Authors:  A Erdei; E Spaeth; J Alsenz; E Rüde; T Schulz; J Gergely; M P Dierich
Journal:  Mol Immunol       Date:  1984-12       Impact factor: 4.407

7.  Dermatitis herpetiformis: biochemical properties of the granular deposits of IgA in papillary dermis. Characterization of SDS-soluble IgA-like material and potentially antigen-binding IgA fragments released by pepsin.

Authors:  T Egelrud; O Bäck
Journal:  J Invest Dermatol       Date:  1985-04       Impact factor: 8.551

8.  C3a(C3adesArg) induces production and release of interleukin 1 by cultured human monocytes.

Authors:  N Haeffner-Cavaillon; J M Cavaillon; M Laude; M D Kazatchkine
Journal:  J Immunol       Date:  1987-08-01       Impact factor: 5.422

9.  The role of hypocomplementaemia and low erythrocyte complement receptor type 1 numbers in determining abnormal immune complex clearance in humans.

Authors:  J A Schifferli; Y C Ng; J P Paccaud; M J Walport
Journal:  Clin Exp Immunol       Date:  1989-03       Impact factor: 4.330

10.  Identification of a nonproteolytically activated C3 with CR 1-binding properties in sera from subjects with primary biliary cirrhosis.

Authors:  B Nilsson; L Lööf; U R Nilsson
Journal:  Int Arch Allergy Appl Immunol       Date:  1986
View more
  3 in total

1.  Impairments in complement receptor- and Fc receptor-mediated functions in vivo in patients with psoriasis.

Authors:  K N Ekdahl; G Michaëlsson; B Gerdén; L Lööf; B Nilsson
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

Review 2.  Coeliac disease: an update for pathologists.

Authors:  B C Dickson; C J Streutker; R Chetty
Journal:  J Clin Pathol       Date:  2006-10       Impact factor: 3.411

3.  Circulating immune-complexes of IgG/IgM bound to B2-glycoprotein-I associated with complement consumption and thrombocytopenia in antiphospholipid syndrome.

Authors:  Laura Naranjo; Ljudmila Stojanovich; Aleksandra Djokovic; Laura Andreoli; Angela Tincani; Maria Maślińska; Savino Sciascia; Maria Infantino; Sara Garcinuño; Kinga Kostyra-Grabczak; Mariangela Manfredi; Francesca Regola; Natasa Stanisavljevic; Milomir Milanovic; Jovica Saponjski; Dario Roccatello; Irene Cecchi; Massimo Radin; Maurizio Benucci; Daniel Pleguezuelo; Manuel Serrano; Yehuda Shoenfeld; Antonio Serrano
Journal:  Front Immunol       Date:  2022-09-12       Impact factor: 8.786

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.